Deanna Mohn
Amgen (United States)(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Protein Kinase Regulation and GTPase Signaling, Chronic Lymphocytic Leukemia Research, Asthma and respiratory diseases, Cytokine Signaling Pathways and Interactions
Most-Cited Works
- → Diverse alterations associated with resistance to KRAS(G12C) inhibition(2021)417 cited
- → Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways(2019)132 cited
- → Discovery and in Vivo Evaluation of (S)-N-(1-(7-Fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and Related PI3Kδ Inhibitors for Inflammation and Autoimmune Disease(2014)85 cited
- → Discovery of Aminoquinazolines as Potent, Orally Bioavailable Inhibitors of Lck: Synthesis, SAR, and in Vivo Anti-Inflammatory Activity(2006)67 cited
- → IL-17RA Signaling in Airway Inflammation and Bronchial Hyperreactivity in Allergic Asthma(2015)67 cited
- → Novel 2-Aminopyrimidine Carbamates as Potent and Orally Active Inhibitors of Lck: Synthesis, SAR, and in Vivo Antiinflammatory Activity(2006)61 cited
- → A nanoparticle vaccine that targets neoantigen peptides to lymphoid tissues elicits robust antitumor T cell responses(2020)52 cited
- → Discovery and in Vivo Evaluation of Dual PI3Kβ/δ Inhibitors(2012)49 cited
- → Discovery, Optimization, and in Vivo Evaluation of Benzimidazole Derivatives AM-8508 and AM-9635 as Potent and Selective PI3Kδ Inhibitors(2015)34 cited
- → Synthesis and SAR study of potent and selective PI3Kδ inhibitors(2015)24 cited